Who are Lisata Therapeutics, Inc.'s main suppliers?

Lisata Therapeutics, Inc. (LSTA) key suppliers include: QILU-PHARMACEUTICAL, AUSTRALASIAN-GASTROINTESTINAL-CLINICAL-TRIALS-GR, CATALENT-INC, UNIVERSITY-OF-SYDNEY. View the full supplier network at chainsifter.com/chain/LSTA.

Who are Lisata Therapeutics, Inc.'s major customers?

Lisata Therapeutics, Inc. (LSTA) key customers include: KUVA-LABS-INC. View the full customer network at chainsifter.com/chain/LSTA.

What sector is Lisata Therapeutics, Inc. in?

Lisata Therapeutics, Inc. (LSTA) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

LSTA Supply Chain: Lisata Therapeutics, Inc. Supplier List & 7 Relationships

4Suppliers

1Customers

2Debt Items

0Related Chains

Lisata Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
QILU-PHARMACEUTICAL	QILU-PHARMACEUTICAL	90%	Study CEND1-201 was conducted in China by our former licensee, Qilu Pharmaceutical.
AUSTRALASIAN-GASTROINTESTINAL-CLINICAL-TRIALS-GR	AUSTRALASIAN-GASTROINTESTINAL-CLINICAL-TRIALS-GR	80%	We collaborated with the academic sponsor of the ASCEND trial, the Australasian Gastrointestinal Clinical Trials Group (AGITG) along with the University of Sydney to conduct the study.
CATALENT-INC	CATALENT-INC	80%	the Company granted to Catalent, on a non-exclusive basis, certain of
UNIVERSITY-OF-SYDNEY	UNIVERSITY-OF-SYDNEY	80%	We collaborated with the academic sponsor of the ASCEND trial, the Australasian Gastrointestinal Clinical Trials Group (AGITG) along with the University of Sydney to conduct the study.

Lisata Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
KUVA-LABS-INC	KUVA-LABS-INC	92%	pursuant to which Kuva and Lisata agreed to negotiate in good faith and enter into a customary purchase agreement to consummate a negotiated acquisition of Lisata by Kuva

Lisata Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
LSTA-DEBT-10807	Warrants outstanding: 10	90%	xbrl warrant detail from xbrl 2021-01-31.
LSTA-DEBT-10808	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2010-12-31.

Lisata Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Lisata Therapeutics, Inc..

Lisata Therapeutics, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Lisata Therapeutics, Inc..

Lisata Therapeutics, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.

Lisata Therapeutics, Inc. Supply Chain